Fanconi anemia complementation group D2 promotes sensitivity of endometrial cancer cells to chemotherapeutic agents by inhibiting the ferroptosis pathway

Resistance can develop during treatment of advanced endometrial cancer (EC), leading to unsatisfactory results. Fanconi anemia complementation group D2 (Fancd2) has been shown to be closely related to drug res...

Source: BMC Women's Health - January 13, 2024 Category: OBGYN Authors: Hai-Hong Lin, Wei-Hong Zeng, Hai-Kun Yang, Li-Shan Huang, Ru Pan and Nan-Xiang Lei Tags: Research Source Type: research